Vertex Pharma (VRTX) Tops Q1 EPS by 72c, Revenues Beat; Raises FY20 Revenues Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 536.28 -16.87 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $553.15 | 52 Week High | $134.71 | |||
| Open | $558.44 | 52 Week Low | $73.31 | |||
| Day High | $561.96 | P/E | N/A | |||
| Day Low | $532.79 | EPS | $-1.98 | |||
| Volume | 1,095,576 | |||||
